Improving Outcomes in Patients With High-Risk Breast Cancer: Expert Guidance and Team Training for HR-Positive/HER2-Negative Disease

This interactive, case-based live workshop series will help to effectively personalize the care of patients with HR-positive/HER2-negative high-risk breast cancer and will provide evidence-based expert perspectives on recent and evolving treatment strategies for the optimal management of patients with these diseases. After the workshop, view the on-demand webcast, download the slideset, and share a communication resource with your patients.

Share

Program Content

Activities

Patient-HCP Checklist
HR-Positive/HER2-Negative Breast Cancer: Patient–Provider Communication Checklist
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 22, 2023

Activities

HR+/HER2- High-Risk BC
Improving Outcomes in Patients With High-Risk Breast Cancer: Expert Guidance and Team Training for HR-Positive/HER2-Negative Disease
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: January 12, 2024

Activities

Expert Guidance on BC
Expert Guidance on Treating HR+/HER2- Breast Cancer to Improve Outcomes
Video
Congratulations: You achieved a completion on 04/09/2022

Released: March 12, 2024

Expires: March 11, 2025

Activities

HR-Positive HER2-Negative BC
Improving Outcomes in Patients With High-Risk Breast Cancer: Expert Guidance and Team Training for HR-Positive/HER2-Negative Disease
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2024

Expires: March 21, 2025

Faculty

cover img faculity

Carey Anders, MD

Professor of Medicine, Division of Medical Oncology
Division Chief of Medical Oncology, Interim
Medical Director of the Duke Center for Brain and Spine Metastasis
Translating Duke Health Scholar
Duke Cancer Institute
Duke University Health System
Durham, North Carolina

cover img faculity

Joyce O'Shaughnessy, MD

Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Chair, Breast Disease Committee
Texas Oncology
Sarah Cannon Research Institute
Dallas, Texas

cover img faculity

Laura M. Spring, MD

Breast Medical Oncologist
Mass General Cancer Center
Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Lilly.

Lilly